SILK
Income statement / Annual
Last year (2023), Silk Road Medical, Inc's total revenue was $177.13 M,
an increase of 27.77% from the previous year.
In 2023, Silk Road Medical, Inc's net income was -$55.74 M.
See Silk Road Medical, Inc’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
| Operating Revenue |
$177.13 M
|
$138.64 M
|
$101.48 M
|
$75.23 M
|
$63.35 M
|
$34.56 M
|
$14.26 M
|
| Cost of Revenue |
$50.05 M |
$37.88 M |
$25.45 M |
$21.29 M |
$15.93 M |
$10.87 M |
$5.13 M |
| Gross Profit |
$127.09 M |
$100.76 M |
$76.03 M |
$53.94 M |
$47.43 M |
$23.68 M |
$9.13 M |
| Gross Profit Ratio |
0.72 |
0.73 |
0.75 |
0.72 |
0.75 |
0.69 |
0.64 |
| Research and Development
Expenses |
$41.32 M
|
$36.45 M
|
$27.11 M
|
$21.27 M
|
$12.27 M
|
$10.26 M
|
$7.24 M
|
| General & Administrative
Expenses |
$144.57 M
|
$115.97 M
|
$96.17 M
|
$75.33 M
|
$62.86 M
|
$34.82 M
|
$20.26 M
|
| Selling & Marketing
Expenses |
$461,000.00
|
$347,000.00
|
$221,000.00
|
$194,000.00
|
$362,000.00
|
$186,000.00
|
$218,000.00
|
| Selling, General &
Administrative Expenses |
$145.03 M
|
$116.32 M
|
$96.39 M
|
$75.52 M
|
$63.22 M
|
$34.82 M
|
$20.26 M
|
| Other Expenses |
$442,000.00 |
-$190,000.00 |
-$23,000.00 |
-$80,000.00 |
-$21.05 M |
-$12.06 M |
$2.93 M |
| Operating Expenses |
$186.36 M |
$152.77 M |
$123.50 M |
$96.80 M |
$75.49 M |
$45.08 M |
$27.50 M |
| Cost And Expenses |
$236.41 M |
$190.64 M |
$148.94 M |
$118.09 M |
$91.42 M |
$55.95 M |
$32.63 M |
| Interest Income |
$9.96 M |
$2.53 M |
$198,000.00 |
$1.10 M |
$1.66 M |
$189,000.00 |
$34,000.00 |
| Interest Expense |
$6.87 M |
$5.10 M |
$2.52 M |
$4.41 M |
$4.95 M |
$4.36 M |
$3.94 M |
| Depreciation &
Amortization |
$3.79 M
|
$3.17 M
|
$1.92 M
|
$1.39 M
|
$1.29 M
|
$517,000.00
|
$128,719.00
|
| EBITDA |
-$45.08 M
|
-$46.74 M
|
-$45.55 M
|
-$41.47 M
|
-$46.17 M
|
-$32.75 M
|
-$18.25 M
|
| EBITDA Ratio |
-0.31 |
-0.36 |
-0.47 |
-0.56 |
-0.42 |
-0.95 |
-1.07 |
| Operating Income Ratio
|
-0.33
|
-0.38
|
-0.47
|
-0.57
|
-0.44
|
-0.62
|
-1.29
|
| Total Other
Income/Expenses Net |
$3.53 M
|
-$3.01 M
|
-$2.34 M
|
-$4.51 M
|
-$24.35 M
|
-$16.24 M
|
-$982,000.00
|
| Income Before Tax |
-$55.74 M |
-$55.01 M |
-$49.81 M |
-$47.37 M |
-$52.42 M |
-$37.63 M |
-$19.36 M |
| Income Before Tax Ratio
|
-0.31
|
-0.4
|
-0.49
|
-0.63
|
-0.83
|
-1.09
|
-1.36
|
| Income Tax Expense |
$43,000.00 |
$3.01 M |
$576,000.00 |
$3.02 M |
$3.66 M |
-$11.87 M |
$6.87 M |
| Net Income |
-$55.74 M |
-$58.02 M |
-$50.39 M |
-$50.39 M |
-$56.07 M |
-$37.63 M |
-$19.36 M |
| Net Income Ratio |
-0.31 |
-0.42 |
-0.5 |
-0.67 |
-0.89 |
-1.09 |
-1.36 |
| EPS |
-1.44 |
-1.62 |
-1.45 |
-1.53 |
-2.44 |
-1.31 |
-0.8 |
| EPS Diluted |
-1.44 |
-1.62 |
-1.45 |
-1.53 |
-2.44 |
-1.31 |
-0.8 |
| Weighted Average Shares
Out |
$38.80 M
|
$35.78 M
|
$34.64 M
|
$32.97 M
|
$22.96 M
|
$28.71 M
|
$24.05 M
|
| Weighted Average Shares
Out Diluted |
$38.80 M
|
$35.78 M
|
$34.64 M
|
$32.97 M
|
$22.96 M
|
$28.71 M
|
$24.05 M
|
| Link |
|
|
|
|
|
|
|
